Decreased expression of the p63 related proteins β-catenin, E-cadherin and EGFR in oral lichen planus

Oral Oncology

Volumn 44, Issue 7, 2008, Pages 634-638

  Ebrahimi, Majid ^a   Boldrup, Linda ^a   Wahlin, Ylva Britt ^a   Coates, Philip J ^b   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

catenin; E cadherin; EGFR; Oral lichen planus; p63

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P63; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MALE; MALIGNANT TRANSFORMATION; MOUTH DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION;

ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 45249090593     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.08.001     Document Type: Article

References (44)

1. Axell T., and Rundquist L. Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 15 (1987) 52-56
2. Sugerman P.B., Savage N.W., Walsh L.J., Zhao Z.Z., Zhou X.J., Khan A., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13 (2002) 350-365
3. Ebrahimi M., Wahlin Y.B., Coates P.J., Wiik A., Roos G., and Nylander K. Detection of antibodies against p63 and p73 isoforms in sera from patients diagnosed with oral lichen planus. J Oral Pathol Med 36 (2007) 93-98
4. Dissemond J. Oral lichen planus: an overview. J Dermatol Treat 15 (2004) 136-140
5. van der Meij E.H., Schepman K.P., Smeele L.E., van der Wal J.E., Bezemer P.D., and van der Waal I. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 307-310
6. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., et al. p63, a p53 homologue at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
7. Thurfjell N., Coates P.J., Uusitalo T., Mahani D., Dabelsteen E., Dahlqvist A., et al. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 25 (2004) 27-35
8. Ebrahimi M, Boldrup L, Coates PJ, Wahlin YB, Bourdon JC, Nylander K. Expression of novel p53 isoforms in oral lichen planus. Oral Oncol, in press. doi:10.1016/j.oraloncology.2007.01.014.
9. Ebrahimi M., Wahlin Y.B., Coates P.J., Sjostrom B., and Nylander K. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation. J Oral Pathol Med 35 (2006) 46-50
10. Sniezek J.C., Matheny K.E., Burkey B.B., Netterville J.L., and Pietenpol J.A. Expression of p63 and 14-3-3σ in normal and hyperdifferentiated mucosa of the upper aerodigestive tract. Otolaryngol Head Neck Surg 126 (2002) 598-601
11. Acay R.R., Felizzola C.R., Soares de Araujo N., and Machado de Sousa S.O. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol 42 (2006) 475-480 Epub 2005 Dec 20
12. Chaiyarit P., Ma N., Hiraku Y., Pinlaor S., Yongvanit P., Jintakanon D., et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 96 (2005) 553-559
13. Girod S.C., Cesarz D., Fischer U., and Krueger G.R. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis. Anticancer Res 15 (1995) 1453-1457
14. Girod S.C., Kramer C., Knufermann R., and Krueger G.R. p53 expression in the carcinogenesis in the oral mucosa. J Cell Biochem 56 (1994) 444-448
15. Hirota M., Ito T., Okudela K., Kawabe R., Yazawa T., Hayashi H., et al. Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus. J Oral Pathol Med 31 (2002) 204-212
16. Lee J.J., Kuo M.Y., Cheng S.J., Chiang C.P., Jeng J.H., Chang H.H., et al. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 471-478
17. Ogmundsdottir H.M., Hilmarsdottir H., Astvaldsdottir A., Johannsson J.H., and Holbrook W.P. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in iceland. Eur J Oral Sci 110 (2002) 192-198
18. Schifter M., Jones A.M., and Walker D.M. Epithelial p53 gene expression and mutational analysis, combined with growth fraction assessment, in oral lichen planus. J Oral Pathol Med 27 (1998) 318-324
19. Ilyas M., and Tomlinson I.P. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 182 (1997) 128-137
20. Barker N., and Clevers H. Catenins, Wnt signalling and cancer. Bioessays 22 (2000) 961-965
21. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
22. Morin P.J. β-catenin signalling and cancer. Bioessays 21 (1999) 1021-1030
23. Patturajan M., Nomoto S., Sommer M., Fomenkov A., Hibi K., Zangen R., et al. ΔNp63 induces β-catenin nuclear accumulation and signalling. Cancer Cell 1 (2002) 369-379
24. Palacios F., Tushir J.S., Fujita Y., and D'Souza-Schorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 25 (2005) 389-402
25. Bremnes R.M., Veve R., Hirsch F.R., and Franklin W.A. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36 (2002) 115-124
26. Wu H., Lotan R., Menter D., Lippman S.M., and Xu X.C. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 20 (2000) 1385-1390
27. Hung K.F., Chang C.S., Liu C.J., Lui M.T., Cheng C.Y., and Kao S.Y. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 35 (2006) 589-594
28. Neppelberg E., Loro L.L., Oijordsbakken G., and Johannessen A.C. Altered CD40 and E-cadherin expression-putative role in oral lichen planus. J Oral Pathol Med 36 (2007) 153-160
29. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237 (1962) 1555-1562
30. Matheny K.E., Barbieri C.E., Sniezek J.C., Arteaga C.L., and Pietenpol J.A. Inhibition of epidermal growth factor receptor signalling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 113 (2003) 936-939
31. Rubin Grandis J., Melhem M.F., Barnes E.L., and Tweardy D.J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78 (1996) 1284-1292
32. Nishi H., Senoo M., Nishi K.H., Murphy B., Rikiyama T., Matsumura Y., et al. p53 Homologue p63 represses epidermal growth factor receptor expression. J Biol Chem 276 (2001) 41717-41724
33. Boldrup L., Coates P.J., Hedberg Y., Sjostrom B., Dahlqvist A., and Nylander K. Expression of p63, COX-2, EGFR and β-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. Int J Oncol 27 (2005) 1661-1667
34. Hall P.A., Campbell S.J., O'Neill M., Royston D.J., Nylander K., Carey F.A., et al. Expression of the p53 homologue p63α and ΔNp63α in normal and neoplastic cells. Carcinogenesis 21 (2000) 153-160
35. Liefer K.M., Koster M.I., Wang X.J., Yang A., McKeon F., and Roop D.R. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 60 (2000) 4016-4020
36. Hildesheim J., Belova G.I., Tyner S.D., Zhou X., Vardanian L., and Fornace Jr. A.J. Gadd45a regulates matrix metalloproteinases by suppressing ΔNp63α and β-catenin via p38 MAP kinase and APC complex activation. Oncogene 23 (2004) 1829-1837
37. Grandis J.R., and Tweardy D.J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53 (1993) 3579-3584
38. Ke L.D., Adler-Storthz K., Clayman G.L., Yung A.W., and Chen Z. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck 20 (1998) 320-327
39. Rubin Grandis J., Tweardy D.J., and Melhem M.F. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res 4 (1998) 13-20
40. Tian X.X., Chan J.Y., Pang J.C., Chen J., He J.H., To T.S., et al. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Br J Cancer 81 (1999) 994-1001
41. Edelman G.M., and Crossin K.L. Cell adhesion molecules: implications for a molecular histology. Annu Rev Biochem 60 (1991) 155-190
42. Neppelberg E., and Johannessen A.C. DNA content, cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol 264 (2007) 1223-1230
43. Galaz S., Espada J., Stockert J.C., Pacheco M., Sanz-Rodriguez F., Arranz R., et al. Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J Cell Physiol 205 (2005) 86-96
44. Peluso J.J., Pappalardo A., and Fernandez G. E-cadherin-mediated cell contact prevents apoptosis of spontaneously immortalised granulosa cells by regulating Akt kinase activity. Biol Reprod 64 (2001) 1183-1190